This inventor holds 2 USPTO granted patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Innovations of John David Graef
Introduction
John David Graef is a notable inventor based in Hingham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 2 patents to his name, Graef's work focuses on addressing critical health issues.
Latest Patents
Graef's latest patents include innovative antibodies to alpha-synuclein. These antibodies preferentially bind to oligomeric alpha-synuclein over monomeric alpha-synuclein. The therapeutic compositions comprising these antibodies are designed to treat synucleinopathies, which are disorders associated with the accumulation of alpha-synuclein in the brain.
Career Highlights
John David Graef is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at Bristol-Myers Squibb has allowed him to contribute to groundbreaking research and development in the field of medicine.
Collaborations
Graef has collaborated with esteemed colleagues, including Michael K Ahlijanian and Jere E Meredith, Jr. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
John David Graef's contributions to the field of biotechnology through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic approaches to treat complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile